Cargando…

Proton Grid Therapy: A Proof-of-Concept Study

In this work, we studied the possibility of merging proton therapy with grid therapy. We hypothesized that patients with larger targets containing solid tumor growth could benefit from being treated with this method, proton grid therapy. We performed treatment planning for 2 patients with abdominal...

Descripción completa

Detalles Bibliográficos
Autores principales: Henry, Thomas, Ureba, Ana, Valdman, Alexander, Siegbahn, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762029/
https://www.ncbi.nlm.nih.gov/pubmed/28592213
http://dx.doi.org/10.1177/1533034616681670
_version_ 1783291620330831872
author Henry, Thomas
Ureba, Ana
Valdman, Alexander
Siegbahn, Albert
author_facet Henry, Thomas
Ureba, Ana
Valdman, Alexander
Siegbahn, Albert
author_sort Henry, Thomas
collection PubMed
description In this work, we studied the possibility of merging proton therapy with grid therapy. We hypothesized that patients with larger targets containing solid tumor growth could benefit from being treated with this method, proton grid therapy. We performed treatment planning for 2 patients with abdominal cancer with the suggested proton grid therapy technique. The proton beam arrays were cross-fired over the target volume. Circular or rectangular beam element shapes (building up the beam grids) were evaluated in the planning. An optimization was performed to calculate the fluence from each beam grid element. The optimization objectives were set to create a homogeneous dose inside the target volume with the constraint of maintaining the grid structure of the dose distribution in the surrounding tissue. The proton beam elements constituting the grid remained narrow and parallel down to large depths in the tissue. The calculation results showed that it is possible to produce target doses ranging between 100% and 130% of the prescribed dose by cross-firing beam grids, incident from 4 directions. A sensitivity test showed that a small rotation or translation of one of the used grids, due to setup errors, had only a limited influence on the dose distribution produced in the target, if 4 beam arrays were used for the irradiation. Proton grid therapy is technically feasible at proton therapy centers equipped with spot scanning systems using existing tools. By cross-firing the proton beam grids, a low tissue dose in between the paths of the elemental beams can be maintained down to the vicinity of a deep-seated target. With proton grid therapy, it is possible to produce a dose distribution inside the target volume of similar uniformity as can be created with current clinical methods.
format Online
Article
Text
id pubmed-5762029
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-57620292018-01-17 Proton Grid Therapy: A Proof-of-Concept Study Henry, Thomas Ureba, Ana Valdman, Alexander Siegbahn, Albert Technol Cancer Res Treat Original Articles In this work, we studied the possibility of merging proton therapy with grid therapy. We hypothesized that patients with larger targets containing solid tumor growth could benefit from being treated with this method, proton grid therapy. We performed treatment planning for 2 patients with abdominal cancer with the suggested proton grid therapy technique. The proton beam arrays were cross-fired over the target volume. Circular or rectangular beam element shapes (building up the beam grids) were evaluated in the planning. An optimization was performed to calculate the fluence from each beam grid element. The optimization objectives were set to create a homogeneous dose inside the target volume with the constraint of maintaining the grid structure of the dose distribution in the surrounding tissue. The proton beam elements constituting the grid remained narrow and parallel down to large depths in the tissue. The calculation results showed that it is possible to produce target doses ranging between 100% and 130% of the prescribed dose by cross-firing beam grids, incident from 4 directions. A sensitivity test showed that a small rotation or translation of one of the used grids, due to setup errors, had only a limited influence on the dose distribution produced in the target, if 4 beam arrays were used for the irradiation. Proton grid therapy is technically feasible at proton therapy centers equipped with spot scanning systems using existing tools. By cross-firing the proton beam grids, a low tissue dose in between the paths of the elemental beams can be maintained down to the vicinity of a deep-seated target. With proton grid therapy, it is possible to produce a dose distribution inside the target volume of similar uniformity as can be created with current clinical methods. SAGE Publications 2016-12-14 2017-12 /pmc/articles/PMC5762029/ /pubmed/28592213 http://dx.doi.org/10.1177/1533034616681670 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Henry, Thomas
Ureba, Ana
Valdman, Alexander
Siegbahn, Albert
Proton Grid Therapy: A Proof-of-Concept Study
title Proton Grid Therapy: A Proof-of-Concept Study
title_full Proton Grid Therapy: A Proof-of-Concept Study
title_fullStr Proton Grid Therapy: A Proof-of-Concept Study
title_full_unstemmed Proton Grid Therapy: A Proof-of-Concept Study
title_short Proton Grid Therapy: A Proof-of-Concept Study
title_sort proton grid therapy: a proof-of-concept study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762029/
https://www.ncbi.nlm.nih.gov/pubmed/28592213
http://dx.doi.org/10.1177/1533034616681670
work_keys_str_mv AT henrythomas protongridtherapyaproofofconceptstudy
AT urebaana protongridtherapyaproofofconceptstudy
AT valdmanalexander protongridtherapyaproofofconceptstudy
AT siegbahnalbert protongridtherapyaproofofconceptstudy